Budget Amount *help |
¥17,810,000 (Direct Cost: ¥13,700,000、Indirect Cost: ¥4,110,000)
Fiscal Year 2014: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2013: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
Fiscal Year 2012: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
|
Outline of Final Research Achievements |
Allergin-1 is an immunotyrosine-based inhibitory motif (ITIM)-bearing immunoglobulin-like receptor and inhibit FcεRI-mediated activating signal in mast cell (MC). We found that Allergin-1 suppress house dust mite (HDM)-induced serum IgE elevation, lung eosinophilia, and methacholin-induced airway hyperresponsiveness (AHR) in vivo. We also found that treatment of mice with Allergin-1-ligand inhibited IgE-dependent passive cutaneous anaphylaxis in vivo. These results indicate that Allergin-1 may be a promising target molecule for therapy against allergic asthma.
|